Search references for LEELAMINE. Phrases containing LEELAMINE
See searches and references containing LEELAMINE!LEELAMINE
Chemical compound
Leelamine (dehydroabietylamine) is a diterpene amine that has weak affinity for the cannabinoid receptors CB1 and CB2, as well as being an inhibitor of
Leelamine
Psychoactive drug from the cannabis plant
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabis_(drug)
Psychoactive component of cannabis
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Tetrahydrocannabinol
JZL184 JZL195 Kaempferol KM-233 L-759,633 L-759,656 LASSBio-881 LBP-1 Leelamine Levonantradol, also known as 'CP 50,5561' LH-21 LY-320,135 LY-2183240
List_of_cannabinoids
Pharmaceutical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
ART26.12
Natural bicyclic sesquiterpene
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Caryophyllene
Minor cannabinoid
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabigerol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Long-term_effects_of_cannabis
Designer drugs
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Synthetic_cannabinoids
Phytocannabinoid discovered in 1940
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabidiol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Oleamide
Chemical compound (fatty acid neurotransmitter)
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Anandamide
Homologue of tetrahydrocannabinol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Tetrahydrocannabivarin
Compounds found in cannabis
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabinoid
Directed movement of vesicles and substances within a cell
research. Transport by multiple-motor proteins Kinesin Adaptor protein Leelamine Dynactin MCOLN2 KIF6, KIF5A, involved in intracellular organelle transport
Intracellular_transport
Naturally-occurring cannabinoid
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabinol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-018
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
O-1269
Synthetic cannabinoid
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Nabilone
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
XLR-11
Synthesis of THC from CBD
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Conversion_of_CBD_to_THC
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
ADB-BUTINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Etrinabdione
Semi-sythetic cannabinoid drug
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Hexahydrocannabiphorol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
2F-QMPSB
Cannabinoid agonist compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Tetrahydrocannabiphorol
Pharmaceutical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
10-Hydroxyhexahydrocannabinol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
5F-ADB
Isomer of tetrahydrocannabinol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Δ8-Tetrahydrocannabinol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabichromene
Group of stereoisomers
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabidivarin
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Effects_of_cannabis
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Rimonabant
Acetate ester of tetrahydrocannabinol (THC)
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
THC-O-acetate
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
2-Arachidonoylglycerol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
CUMYL-3TMS-PRINACA
Active metabolite of Δ9-THC
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
11-Hydroxy-THC
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabicyclohexanol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Dimethylheptylpyran
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
SDB-006
THC precursor
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Tetrahydrocannabinolic_acid
Proposed mechanism of cannabis compounds
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Entourage_effect
Pharmaceutical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
10-Hydroxy-HHCP
Active metabolite of paracetamol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AM404
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
MDMB-4en-PINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
5F-EMB-PINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Olorinab
Isomer of tetrahydrocannabinol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Δ11-Tetrahydrocannabinol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AM-919
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Pravadoline
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
IDFP
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-249
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-366
Main secondary metabolite of THC
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
11-Nor-9-carboxy-THC
Group of stereoisomers
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-005
Synthetic cannabinoid
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
HU-210
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Dexanabinol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
CUMYL-4CN-BINACA
Pharmaceutical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-5'F-BUTINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
WIN_55,212-2
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AM-2201
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-CHMINACA
Phytocannabinoid compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Isotetrahydrocannabinol
Pharmaceutical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
Cis enantiomer of tetrahydrocannabidiol
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cis-THC
Substances synthesized by John W. Huffman's research group
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
List_of_JWH_cannabinoids
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
MDMB-BINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
MDMB-FUBINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
ADB-FUBINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
PB-22
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-PINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
APINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
5F-APINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
APICA (synthetic cannabinoid drug)
APICA_(synthetic_cannabinoid_drug)
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-FUBINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AMB-FUBINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
UR-144
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
NMP-7
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Lenabasum
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
AB-001
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-210
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
CP_55,940
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-133
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
N-Arachidonoyl_dopamine
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-359
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
LASSBio-881
Cannabinoid agonist compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
CP_47,497
Synthetic homologue of THC
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Parahexyl
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
ADB-CHMINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JWH-007
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
MDMB-CHMICA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabidiol_diacetate
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Lixosicone
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
5F-PB-22
Phytocannabinoid
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
Cannabidiorcol
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
JTE-907
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
HU-331
Synthetic cannabinoid, designer drug
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
ADB-5'Br-PINACA
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
RCS-4
Chemical compound
CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7 MEPIRAPIM NESS-040C5 NMDMSB NMP-7 O-1269 O-1270 O-1399 O-1602
5F-AMB
LEELAMINE
LEELAMINE
LEELAMINE
LEELAMINE
Boy/Male
Arabic
Clever; Wise
Girl/Female
Gujarati, Indian
Friendly; Generous Person
Boy/Male
Hindu, Indian
Son of a God
Boy/Male
Arabic, Muslim
Unknown; Mystery; Maze
Boy/Male
Arabic, Indian, Muslim, Russian
Rich; Leader; From Kikuyu; Wealthy; Ruler; King
Boy/Male
Hindu, Indian
Son of Lord Rama
Boy/Male
Indian, Sanskrit
Ruler of Janaki
Boy/Male
American, Australian, French, Latin, Portuguese
Timekeeper; Has Good Eyesight
Boy/Male
Shakespearean Gaelic Scottish
The Tragedy of Macbeth' A nobleman of Scotland.
Girl/Female
Afghan, Arabic, Gujarati, Hindu, Indian, Kannada, Muslim
Purity
LEELAMINE
LEELAMINE
LEELAMINE
LEELAMINE
LEELAMINE